(Q34521387)

2 August 2017

1 reference

title

Vancomycin-resistant enterococci: why are they here, and where do they come from? (English)

1 reference

2 August 2017

1 reference

M J Bonten

1

1 reference

PubMed ID

11871804

2 August 2017

R Willems

series ordinal

2

1 reference

PubMed ID

11871804

2 August 2017

R A Weinstein

series ordinal

3

1 reference

2 August 2017

1 December 2001

1 reference

Lancet Infectious Diseases

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

5

1 reference

2 August 2017

314-325

1 reference

Epidemiology of drug resistance: implications for a post-antimicrobial era

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Emergence of Enterococcus as a Significant Pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

A 25-year study of nosocomial bacteremia in an adult intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Vancomycin-resistant enterococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Enterobacter species in a pediatric hospital: horizontal transfer or selection in individual patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

"Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Historical yearly usage of vancomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Emergence of vancomycin-resistant enterococci in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Emergence of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Control of vancomycin-resistant enterococcus in health care facilities in a region.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Insights into the epidemiology and control of infection with vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Prevalence of vancomycin-resistant enterococci in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Enterococci as emerging pathogens of humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Vancomycin-resistant enterococci in cats and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Historical yearly usage of glycopeptides for animals and humans: the American-European paradox revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

1 reference

7 January 2021

Vancomycin-resistant enterococci in vegetarians

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Antimicrobial resistance in enterococci isolated from Turkey flocks fed virginiamycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

The effect of banning avoparcin on VRE carriage in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Host specificity of vancomycin-resistant Enterococcus faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Glycopeptide resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Diversity of Tn1546 elements in clinical isolates of glycopeptide-resistant enterococci from Scottish hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enterococci from humans, pigs, and poultry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Internal size variations in Tn1546-like elements due to the presence of IS1216V.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Enterococcal vanB resistance locus in anaerobic bacteria in human faeces

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Variant esp gene in vancomycin-sensitive Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Frequency of esp in Enterococcus faecium isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900145-1

7 January 2021

10.1016/S1473-3099(01)00145-1

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11871804